Mindfulness Meditation and Sleep Disturbances in Hematopoietic Cell Transplant Patients: Inflammatory Mechanisms MINDFULNESS AWARENESS VS. SLEEP HEALTH EDUCATION

What's the purpose of this trial?

This randomized, controlled study will compare Mindfulness Awareness Practices for Insomnia (MAP-I) to sleep health education (SHE) in subjects receiving autologous hematopoietic cell transplant for multiple myeloma.

This trial is currently open and accepting patients.

What will happen during the trial?

You may be able to join this trial if you:

The following criteria is a partial list of reasons why patients may be eligible to participate in this clinical trial. Further evaluation with a medical professional is required.

Inclusion Criteria:

* ≥18 years of age
* ≤ 1 year since initiation of systemic anti-myeloma therapy
* No prior progression or relapse of myeloma prior to HCT
* Patient should be eligible to receive melphalan 200 mg/m2 as conditioning regimen
* Stem cell graft with \> 2.0 x10\^6 cluster of differentiation 34 cells (CD34+)/kg available for transplant
* Karnofsky Performance Score (KPS) ≥70
* Agreeable to random assignment and data collection, including survey completion and blood draws
* Available to attend the outpatient intervention portion.
* Voluntary written consent must be given before performance of any study related procedure not part of standard medical care, with the understanding that consent may be withdrawn by the subject at any time without prejudice to future medical care

Exclusion Criteria:

* Prior autologous HCT
* Outpatient HCT
* Presence of coexistent amyloidosis
* Presence of known Obstructive Sleep Apnea (OSA)

Additional Trial Information

Enrollment: 7 patients (estimated)

View More

Trial Locations

All Trial Locations

View all clinical trial locations sorted by state.


Medical College of Wisconsin Froedtert Hospital

Milwaukee, WI

Open and Accepting
Interested in this trial?
  • Call us today 😀 keyboard_arrow_right

    We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.

    (888) 828-2206
  • If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.

  • Talk to your doctor keyboard_arrow_right

    You can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.

Still need help? Send us a message